WATSON 408 (Lisinopril 20 mg)
Pill with imprint WATSON 408 is Yellow, Round and has been identified as Lisinopril 20 mg. It is supplied by Watson Pharmaceuticals.
Lisinopril is used in the treatment of diabetic kidney disease; heart attack; high blood pressure; heart failure and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Lisinopril 20 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WATSON 408
Lisinopril
- Imprint
- WATSON 408
- Strength
- 20 mg
- Color
- Yellow
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Angiotensin converting enzyme inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Pharmaceuticals
- Inactive Ingredients
-
silicon dioxide,
calcium phosphate dihydrate dibasic,
FD&C Yellow No. 5,
magnesium stearate,
mannitol,
corn starch
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00591-0408 | Watson Pharmaceuticals, Inc. |
| 63739-0350 | McKesson Packaging Services |
| 43063-0007 | PDRX Pharmaceuticals Inc. (repackager) |
More about lisinopril
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 564 Reviews
- Drug class: Angiotensin Converting Enzyme Inhibitors
- FDA Alerts (1)
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.